Editorial: A year in review: discussions in cellular endocrinology
- PMID: 37854180
- PMCID: PMC10581340
- DOI: 10.3389/fendo.2023.1279895
Editorial: A year in review: discussions in cellular endocrinology
Keywords: diabetes; peroxisome proliferator-activated receptor; phosphoinositides; steroidogenesis; vasopressin receptor.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures
Comment on
- Editorial on the Research TopicA year in review: discussions in cellular endocrinology
References
-
- International Diabetes Federation . IDF Diabetes Atlas. Brussels, Belgium: International Diabetes Federation; (2021).
-
- FDA Approves First Cellular Therapy to Treat Patients with Type 1 Diabetes 2023 . Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-first-c....
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
